Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference.

Neuroscience letters - 4 Nov 2005

Zalewska-Kaszubska Jadwiga, Cwiek Wojciech, Dyr Wanda, Czarnecka Elzbieta

Abstract excerpt

The aim of this study was to evaluate the beta-endorphin (beta-endorphin) plasma level in Warsaw Low Preferring (WLP) and Warsaw high-preferring (WHP) rats after repeated administration of acamprosate, one of most effective drug in the treatment of alcoholism. Treatment with acamprosate in dose 200mg/kg, p.o. for 10 days induced an increase in plasma beta-endorphin levels. A single injection of ethanol also...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alcoholism
Share to Brain
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Interactions

Share to Ethanol

Share to Taurine

Share to Treatment Outcome

Share to Up-Regulation

Source

Identifiers

PMID: 16009491
DOI: 10.1016/j.neulet.2005.06.032

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference.PMID 16009491Read ↗

Delta-opioid receptor antagonism leads to excessive ethanol consumption in mice with enhanced activity of the endogenous opioid system.Semantic proximity Read ↗

Preliminary phenotypic characterization of the Warsaw High Preferring (WHP) and Warsaw Low Preferring (WLP) lines of rats selectively bred for high and low ethanol consumption.Semantic proximity Read ↗

Warsaw high-preferring (WHP) and Warsaw low-preferring (WLP) lines of rats selectively bred for high and low voluntary ethanol intake: preliminary phenotypic characterization.Semantic proximity Read ↗

Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.Semantic proximity Read ↗

Spontaneous and ethanol-stimulated in vitro release of beta-endorphin by the hypothalamus of AA and ANA rats.Semantic proximity Read ↗

Identification of individual differences in response to methadone, buprenorphine, and naltrexone in animal models of opioid use disorderSemantic proximity Read ↗

Deficit in beta-endorphin peptide and tendency to alcohol abuse.Semantic proximity Read ↗

Advances in the use of naltrexone: an integration of preclinical and clinical findings.Semantic proximity Read ↗

Activation of σ-receptors induces binge-like drinking in Sardinian alcohol-preferring rats.Semantic proximity Read ↗

Effects of acamprosate on sensitization to the locomotor-stimulant effects of alcohol in mice selectively bred for high and low alcohol preference.Semantic proximity Read ↗

Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans.Semantic proximity Read ↗

Effects of Ayahuasca on Ethanol-Conditioned Place Preference and ΔFosB Expression in the Nucleus Accumbens in MiceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.